![]() |
|
|
Vol. 286, Issue 2, 1094-1102, August 1998
Molecular Pharmacology Unit, Alcon Laboratories Inc., Fort Worth,
Texas
Specific binding of [3H]prostaglandin (PG)
E1, [3H]PGE2 and
[3H]PGF2 to washed total
particulate homogenates of bovine corpus luteum comprised 60 to 82% of
total binding. Scatchard analysis of competition data revealed the
presence of an apparent single population of binding sites for
[3H]PGE1 and
[3H]PGE2 with dissociation constants
(Kds) of 2.76 to 3.39 nM and apparent
receptor density (Bmax) of 1.5 to 1.56 pmol/g wet
weight (n = 3-4). However,
[3H]PGF2 appeared to interact
with two classes/states of binding sites
(Kd1 = 6.51 ± 0.65 nM,
Bmax1 = 2.33 ± 0.26 pmol/g wet weight;
Kd2 = 986 ± 269 nM;
Bmax2 = 44.8 ± 11.3 pmol/g wet weight,
n = 11). Specific
[3H]PGE1 and
[3H]PGE2 binding was most potently (nanomolar
affinity) inhibited by PGs with high selectivity for the
EP3 receptor subtype (e.g., GR63799,
sulprostone, enprostil) but was weakly
(Kis > 1 µM) influenced by
EP1-selective (SC-19220), FP-selective
(fluprostenol, PHXA85), DP-selective (BWA868C; ZK118182), IP-selective
(iloprost) and TP-selective (U46619) PGs. Specific
[3H]PGF2 binding was potently
displaced by FP-selective agents such as fluprostenol, PHXA85 and
cloprostenol with nanomolar affinities (n = 3-25),
but weakly (Kis > 1 µM) by other
PGs showing high selectivity for other PG receptor subtypes mentioned
above. The relative specificities and potencies of
EP3- and FP-selective PGs tested in the binding
assays were confirmed using various functional assays. These studies
have provided strong pharmacological evidence for the similarity of
[3H]PGE1 and
[3H]PGE2 binding to EP3 receptors
and for [3H]PGF2 binding to FP
receptors in washed bovine corpus luteum homogenates.